World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
130
Citations
57053
World Ranking
2506
National Ranking
1412

Overview

David M. Gershenson is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focuses primarily on medical fields related to reproductive health and oncology, with a significant emphasis on ovarian cancer diagnosis and treatment.

The main fields of study for this scientist include Medicine, with notable subfields in Reproductive Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, and Obstetrics and Gynecology.

Their research topics cover a variety of cancer-related subjects, including:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • Renal cell carcinoma treatment
  • Cancer Mechanisms and Therapy
  • PARP inhibition in cancer therapy
  • Cancer Genomics and Diagnostics

Frequent coauthors in their publications are:

  • Shannon N. Westin
  • Anil K. Sood
  • R. Tyler Hillman
  • Robert L. Coleman
  • Lauren Cobb

Their work has been published frequently in the following venues:

  • Gynecologic Oncology
  • International Journal of Gynecological Cancer
  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research

Recent papers authored or coauthored by David M. Gershenson include:

  • Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2021, Journal of the National Comprehensive Cancer Network
  • NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022, 2022, Journal of the National Comprehensive Cancer Network
  • MEK inhibitor resistance mechanisms and recent developments in combination trials, 2020, Cancer Treatment Reviews
  • Low-grade serous ovarian cancer: State of the science, 2020, Gynecologic Oncology
  • EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer., 2021, Journal of Clinical Oncology

Best Publications

  • Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

    Mitchell Morris;Patricia J. Eifel;Jiandong Lu;Perry W. Grigsby

  • Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

    Premal H Thaker;Liz Y Han;Aparna A Kamat;Jesusa M Arevalo

  • Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01

    Patricia J Eifel;Kathryn Winter;Mitchell Morris;Charles F Levenback

  • Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome

    Kathleen M. Schmeler;Henry T. Lynch;Lee-May Chen;Mark F. Munsell

  • Grading ovarian serous carcinoma using a two-tier system.

    Anais Malpica;Michael T. Deavers;Karen Lu;Diane C. Bodurka

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • Stress hormone-mediated invasion of ovarian cancer cells.

    Anil K. Sood;Robert Bhatty;Aparna A. Kamat;Charles N. Landen

  • Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

    Karen H. Lu;Andrea P. Patterson;Lin Wang;Rebecca T. Marquez

  • Quality of Life and Sexual Functioning in Cervical Cancer Survivors

    Michael Frumovitz;Charlotte C Sun;Leslie R. Schover;Mark F. Munsell

  • Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB Pathway

    Yvonne G. Lin;Ajaikumar B. Kunnumakkara;Asha Nair;William M. Merritt

  • Ovarian cancer, version 2.2020

    Deborah K. Armstrong;Ronald D. Alvarez;Jamie N. Bakkum-Gamez;Lisa Barroilhet

  • Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study

    Thomas W. Burke;Charles Levenback;Carmen Tornos;Mitchell Morris

  • Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

    Charles N. Landen;Blake Goodman;Ashwini A. Katre;Adam D. Steg;Adam D. Steg

  • Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

    Karen H. Lu;Mai Dinh;Wendy Kohlmann;Patrice Watson

  • Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

    John Farley;William E Brady;Vinod Vathipadiekal;Heather A Lankes

  • Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

    Brian M Slomovitz;Thomas W Burke;Patricia J Eifel;Lois M Ramondetta

  • Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.

    Diane Bodurka-Bevers;Karen Basen-Engquist;Cindy L. Carmack;Mary A. Fitzgerald

  • Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

    Tomas Bonome;Ji Young Lee;Dong Choon Park;Mike Radonovich

  • Risk Factors for Young Premenopausal Women With Endometrial Cancer

    Pamela T. Soliman;Jonathan C. Oh;Kathleen M. Schmeler;Charlotte C. Sun

  • Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

    Jyotsnabaran Halder;Aparna A. Kamat;Charles N. Landen;Liz Y. Han

Frequent Co-Authors

Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Anil K. Sood
Anil K. Sood The University of Texas MD Anderson Cancer Center
Elvio G. Silva
Elvio G. Silva The University of Texas MD Anderson Cancer Center
Robert L. Coleman
Robert L. Coleman The University of Texas MD Anderson Cancer Center
Michael T. Deavers
Michael T. Deavers Houston Methodist
Anais Malpica
Anais Malpica The University of Texas MD Anderson Cancer Center
John J. Kavanagh
John J. Kavanagh The University of Texas MD Anderson Cancer Center
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Russell Broaddus
Russell Broaddus University of North Carolina at Chapel Hill
Patricia J. Eifel
Patricia J. Eifel The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees in healthcare can open various doors for those interested in medicine. For nursing professionals aiming to advance academically, consider phd nursing programs online, which offer flexible learning schedules and the chance to lead in clinical research or education.

Many registered nurses look to earn higher credentials through an rn to bsn online program—these bridge programs are designed with working professionals in mind and can help increase earning potential and job opportunities.

If you hold a non-nursing bachelor’s degree but want to pivot into nursing, accelerated options like online direct entry msn programs let you fast-track your pathway to advanced nursing roles.

For those concerned about admissions, there are also easy nursing schools to get into that offer a supportive entry into the healthcare workforce. These diverse pathways ensure flexible entry points for aspiring healthcare professionals.

Best Scientists Citing David M. Gershenson

Trending Scientists

Recently Published Articles